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In the human pathogenic bacterium Pseudomonas aeruginosa, GDP-mannose 
dehydrogenase (GMD) serves as a critical enzyme in the biosynthesis of 
alginate, a polysaccharide that functions as a protective coating against 
antibiotics and immune system responses. Infection is particularly 
problematic in cystic fibrosis and burn victims, as P. aeruginosa uses 
alginate to form dense, protected colonies that can often be fatal to the 
host. GMD catalyzes the oxidation of GDP-mannose to GDP-mannuronic acid, 
using two equivalents of NAD+ as cofactors for the reaction. The gene for 
GMD, AlgD, has been sequenced and the enzyme has been examined via X-ray 
crystallography, allowing for an analysis of mutations of specific amino acid 
residues within the active site of the enzyme. Kinetic studies of single and 
double mutations of cysteine and glutamate residues within the active site, 
C268 and E157, respectively, have been carried out using ultraviolet 
spectrophotometry and fluorimetry. These mutations have been characterized 
and compared with wild-type enzyme, using Michaelis-Menten and Hill analysis 
to determine the effect of the mutated residue on specific activity, 
substrate binding and inhibition, and the allosteric effects of GMP, a known 
inhibitor of wild-type GMD. Through analysis of these mutations, a more 
thorough understanding of the structure of GMD and the mechanism by which it 
acts can be reached. In conjunction with further characterization of C268 and 
E157, a study of other potential active site residues will give insight into 
the mechanism of GMD and potentially allow for work to begin on a functional 
inhibitor of this committed step in the biosynthetic pathway of bacterial 
alginate. 
 
